Citrate enhances in vitro metastatic behaviours of PC-3M human prostate cancer cells: Status of endogenous citrate and dependence on aconitase and fatty acid synthase

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 10, 2006, Pages 1766-1777

  Mycielska, Maria E ^a   Broke Smith, Timothy P ^a   Palmer, Christopher P ^a   Beckerman, Rachel ^a   Nastos, Theodoros ^a   Erguler, Kamil ^a   Djamgoz, Mustafa B A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Aconitase; Citrate; Fatty acid synthase; Metabolism; Prostate cancer

Indexed keywords

ACONITATE HYDRATASE; CELL ENZYME; CERULENIN; CITRIC ACID; ENZYME INHIBITOR; FATTY ACID SYNTHASE; FATTY ACID SYNTHASE INHIBITOR; FLUOROCITRIC ACID; MESSENGER RNA; OXALOMALATE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ACTIVITY; CELL ADHESION; CELL FUNCTION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME METABOLISM; HUMAN; HUMAN CELL; IN VITRO SELECTION; INCUBATION TIME; METASTASIS; MITOCHONDRION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

ACONITATE HYDRATASE; BIOLOGICAL TRANSPORT; CELL ADHESION; CELL LINE, TUMOR; CITRIC ACID; CYTOSOL; FATTY ACID SYNTHETASE COMPLEX; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 33746835711     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.04.008     Document Type: Article

References (38)

1. Adamson J., Morgan E.A., Beesley C., Mei Y., Foster C.S., Fujii H., et al. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 22 (2003) 2739-2749
2. Baron A., Migita T., Tang D., and Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer?. Journal of Cell Biochemistry 91 (2004) 47-53
3. Costello L.C., and Franklin R.B. Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate. Enzyme 26 (1981) 281-287
4. Costello L.C., and Franklin R.B. Concepts of citrate production and secretion by prostate. 1. Metabolic relationships. Prostate 18 (1991) 25-46
5. Costello L.C., and Franklin R.B. Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostate. Prostate 19 (1991) 181-205
6. Costello L.C., and Franklin R.B. Bioenergetic theory of prostate malignancy. Prostate 25 (1994) 162-166
7. Costello L.C., Franklin R.B., and Narayan P. Citrate in the diagnosis of prostate cancer. Prostate 38 (1999) 237-245
8. Costello L.C., Franklin R.B., Liu Y., and Kennedy M.C. Zinc causes a shift toward citrate at equilibrium of the m-aconitase reaction of prostate mitochondria. Journal of Inorganic Biochemistry 78 (2000) 161-165
9. Diss J.K., Stewart D., Pani F., Foster C.S., Walker M.M., Patel A., et al. A potential novel marker for human prostate cancer: Voltage-gated sodium channel expression in vivo. Prostate Cancer & Prostatic Diseases 8 (2005) 266-273
10. Drapier J.C., and Hibbs Jr. J.B. Aconitases: A class of metalloproteins highly sensitive to nitric oxide synthesis. Methods in Enzymology 269 (1996) 26-36
11. Festa M., Colonna A., Pietropaolo C., and Ruffo A. Oxalomalate, a competitive inhibitor of aconitase, modulates the RNA-binding activity of iron-regulatory proteins. Biochemical Journal 348 (2000) 315-320
12. Fraser S.P., Ding Y., Liu A., Foster C.S., and Djamgoz M.B.A. Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line. Cell & Tissue Research 295 (1999) 505-512
13. + channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. Journal of Cell Physiology 195 (2003) 479-487
14. + currents in two prostatic tumour cell lines: Contribution to invasiveness in vitro. FEBS Letters 369 (1995) 290-294
15. Hering-Smith K.S., Gambala C.T., and Hamm L.L. Citrate and succinate transport in proximal tubule cells. American Journal of Physiology - Renal Physiolgy 278 (2000) F492-F498
16. Hochachka P.W., Rupert J.L., Goldenberg L., Gleave M., and Kozlowski P. Going malignant: The hypoxia-cancer connection in the prostate. BioEssays 24 (2002) 749-757
17. Huang P.L., Zhu S.N., Lu S.L., Dai Z.S., and Jin Y.L. Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells. World Journal of Gastroenterology 6 (2000) 295-297
18. Inoue K., Zhuang L., Maddox D.M., Smith S.B., and Ganapathy V. Structure, function, and expression pattern of a novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain. Journal of Biological Chemistry 277 (2002) 39469-39476
19. Kavanagh J.P. Isocitric and citric acid in human prostatic and seminal fluid: Implications for prostatic metabolism and secretion. Prostate 24 (1994) 139-142
20. Kuhajda F.P., Pizer E.S., Li J.N., Mani N.S., Frehywot G.L., and Towsend C.A. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proceedings of National Academy of Sciences USA 97 (2000) 3450-3454
21. Lian X.Y., and Stringer J.L. Inhibition of aconitase in astrocytes increases the sensitivity to chemical convulsants. Epilepsy Research 60 (2004) 41-52
22. (-ΔΔC(T)). Methods 25 (2001) 402-408
23. Menendez J.A., Lupu R., and Colmer R. Targeting fatty acid synthase: Potential for therapeutic intervention in her-2/neu-overexpressing breast cancer. Drugs News & Perspectives 18 (2005) 375-385
24. Murray B., and Wilson D.J. A study of metabolites as intermediate effectors in angiogenesis. Angiogenesis 4 (2001) 71-77
25. + channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity. Journal of Cell Physiology 195 (2003) 461-469
26. Mycielska M.E., and Djamgoz M.B. Citrate transport in the human prostate epithelial PNT2-C2 cell line: Electrophysiological analyses. Journal of Physiology 559 (2004) 821-833
27. + channel activity. Journal of Physiology 563 (2005) 393-408
28. Mycielska M.E., Krasowska M., Grzywna Z., and Djamgoz M.B. Endogenous and exogenous citrate transport and release in prostatic preparations: Semi-polarized two-dimensional cultures of human PNT2-C2 cells and isolated tubules and segments of rat prostate. Prostate 65 (2005) 88-99
29. Narahari J., Ma R., Wang M., and Walden W.E. The aconitase function of iron regulatory protein 1. Genetic studies in yeast implicate its role in iron-mediated redox regulation. Journal of Biological Chemistry 275 (2000) 16227-16234
30. + channel expression in vitro. Journal of Membrane Biology 204 (2005) 67-75
31. + channel expression.
32. Petrarulo M., Facchini P., Cerelli E., Marangella M., and Linari F. Citrate in urine determined with a new citrate lyase method. Clinical Chemistry 41 (1995) 1518-1521
33. Pitula J.S., Deck K.M., Clarke S.L., Anderson S.A., Vasanthakumar A., and Eisenstein R.S. Selective inhibition of the citrate-to-isocitrate reaction of cytosolic aconitase by phosphomimetic mutation of serine-711. Proceedings of National Academy of Science U S A 101 (2004) 10907-10912
34. Schmid B., Rippmann J.F., Tadayyon M., and Hamilton B.S. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochemical & Biophysical Research Communications 328 (2005) 1073-1082
35. Silletti S., Yao J.P., Pienta K.J., and Raz A. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells. International Journal of Cancer 63 (1995) 100-105
36. Swinnen J.V., Roskams T., Joniau S., Van Poppel H., Oyen R., Baert L., et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. International Journal of Cancer 98 (2002) 19-22
37. i increase and its transcriptional activation of immediate early genes is important in the regulation of motility. Experimental Cell Research 246 (1999) 319-326
38. Tsui K.H., Chang P.L., and Juang H.H. Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells. International Journal of Cancer 118 (2006) 609-615